Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety of mesenchymal stromal cells (MSCs) obtained from umbilical cords for the treatment of adults with active systemic lupus erythematosus (SLE).


Clinical Trial Description

This open label trial will evaluate the safety of allogeneic MSCs for the treatment of adults with moderate to severely active systemic lupus erythematosus (SLE). MSCs will be derived from healthy donor umbilical cord cells and 1 dose of MSCs will be tested. MUSC has a good manufacturing practice (GMP) quality Clean Cell Facility to ensure the quality and safety of the MSCs prior to infusing into study participants. The goal of this study is to determine the safety of MSC infusion in patients with SLE when added to standard of care for SLE.

The MSCs used in this trial are cells that are obtained from the umbilical cords of healthy donors having an elective Caesarean section and who have been screened to be sure that they are free of any infectious diseases. These investigational cells will be collected and processed so that they can be used as an infusion treatment. An infusion is when a drug (in this case the MSCs) is administered directly into the blood stream via a vein, usually located in the arm or hand. All participants will receive standard of care and their safety will be monitored throughout the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03171194
Study type Interventional
Source Medical University of South Carolina
Contact
Status Completed
Phase Phase 1
Start date April 27, 2017
Completion date October 25, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04024306 - Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
Active, not recruiting NCT04018222 - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed NCT04527172 - Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
Completed NCT05458531 - Monitoring of Inflammatory Conditions
Completed NCT04970199 - Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus N/A
Completed NCT03426384 - FLARE Lupus Research Study Systemic Lupus Erythematosus N/A
Recruiting NCT05984316 - Systemic Lupus Erythematosus N/A
Recruiting NCT06383104 - Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus. N/A
Not yet recruiting NCT05314881 - NCF Gene & TNFSF4 in SLE Patients N/A
No longer available NCT04907175 - Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)